Trial
NCT04285749
Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Malignant Melanoma
Intervention
Fluvastatin
Why stopped
PI moving to new institution prior to study activation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-27